Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shake off the weight? vibration therapy put to the test against obesity

NCT ID NCT07729215

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial tests whether standing on a vibrating platform for short sessions, twice a week, can boost heat production (thermogenesis), improve heart health markers, and reduce inflammation in adults with obesity. Participants will be assigned to one of two types of vibrating platforms or a placebo platform that makes noise but does not vibrate. The goal is to see if this passive therapy can offer a simple, non-drug approach to improving metabolic and physical health.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
systemic vibration therapy using a vibrating platform
What this could lead to
If effective, vibration therapy could offer a low-effort, drug-free way to help manage obesity by boosting calorie burn and reducing inflammation.
What could go wrong
This is a small, early-stage trial. The placebo effect or the specific vibration settings may not produce meaningful health changes, and results may not apply to all people with obesity.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

90 people

The number who actually took part.

Started

Oct 2024

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 59 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Individuals aged 18 to 59 years; * Both sexes; * Diagnosis of obesity, defined as a body mass index (BMI) ≥ 30 kg/m²; * Waist-to-height ratio (≥ 0.50). Exclusion Criteria: * Presence of metallic prostheses; * Presence of a pacemaker; * Uncontrolled and untreated hypertension (≥180/120 mmHg); * History of labyrinthitis; * Previous diagnosis of deep vein thrombosis; * Pregnancy; * Recent surgery (within the previous 6 months); * Neurodegenerative, pulmonary, or infectious diseases; * Inability to undergo the proposed assessments and/or interventions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Obese adults are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Laboratório de Vibrações Mecânicas e Práticas Integrativas - Policlínica Universitária Piquet Carneiro

    Rio de Janeiro, Rio de Janeiro, 20950-003, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.